157 related articles for article (PubMed ID: 19859041)
1. Clinically-relevent orthotopic metastatic models of pancreatic cancer imageable with fluorescent genetic reporters.
Bouvet M; Hoffman RM
Minerva Chir; 2009 Oct; 64(5):521-39. PubMed ID: 19859041
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
Bouvet M; Hoffman RM
Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
[TBL] [Abstract][Full Text] [Related]
3. Tumor imaging technologies in mouse models.
Bouvet M; Hoffman RM
Methods Mol Biol; 2015; 1267():321-48. PubMed ID: 25636477
[TBL] [Abstract][Full Text] [Related]
4. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
Hoffman RM; Bouvet M
Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
[TBL] [Abstract][Full Text] [Related]
5. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
Clin Exp Metastasis; 2004; 21(1):7-12. PubMed ID: 15065597
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
7. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
Bouvet M; Wang J; Nardin SR; Nassirpour R; Yang M; Baranov E; Jiang P; Moossa AR; Hoffman RM
Cancer Res; 2002 Mar; 62(5):1534-40. PubMed ID: 11888932
[TBL] [Abstract][Full Text] [Related]
8. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models.
Bouvet M; Yang M; Nardin S; Wang X; Jiang P; Baranov E; Moossa AR; Hoffman RM
Clin Exp Metastasis; 2000; 18(3):213-8. PubMed ID: 11315094
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging].
Yu ZQ; Zhou JH; Tao KT; Hu L; Zheng J; Yang DT
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1092-5. PubMed ID: 19781277
[TBL] [Abstract][Full Text] [Related]
10. Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens.
Suetsugu A; Katz M; Fleming J; Truty M; Thomas R; Moriwaki H; Bouvet M; Saji S; Hoffman RM
J Cell Biochem; 2012 Jul; 113(7):2290-5. PubMed ID: 22573550
[TBL] [Abstract][Full Text] [Related]
11. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825
[TBL] [Abstract][Full Text] [Related]
12. Tumor imaging with multicolor fluorescent protein expression.
Yamamoto N; Tsuchiya H; Hoffman RM
Int J Clin Oncol; 2011 Apr; 16(2):84-91. PubMed ID: 21347627
[TBL] [Abstract][Full Text] [Related]
13. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
[TBL] [Abstract][Full Text] [Related]
14. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389
[TBL] [Abstract][Full Text] [Related]
15. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
[TBL] [Abstract][Full Text] [Related]
16. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
Bouvet M; Spernyak J; Katz MH; Mazurchuk RV; Takimoto S; Bernacki R; Rustum YM; Moossa AR; Hoffman RM
Cancer Res; 2005 Nov; 65(21):9829-33. PubMed ID: 16267005
[TBL] [Abstract][Full Text] [Related]
17. Visualization of GFP-expressing tumors and metastasis in vivo.
Hoffman RM
Biotechniques; 2001 May; 30(5):1016-22, 1024-6. PubMed ID: 11355337
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice.
Suetsugu A; Katz M; Fleming J; Truty M; Thomas R; Saji S; Moriwaki H; Bouvet M; Hoffman RM
Anticancer Res; 2012 Aug; 32(8):3063-7. PubMed ID: 22843874
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient-Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice.
Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Miyake K; Kanaya F; Singh A; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Oct; 118(10):3367-3371. PubMed ID: 28300287
[TBL] [Abstract][Full Text] [Related]
20. Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.
Murakami T; Hiroshima Y; Miyake K; Hwang HK; Kiyuna T; DeLong JC; Lwin TM; Matsuyama R; Mori R; Kumamoto T; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
Cell Cycle; 2017 May; 16(10):1008-1014. PubMed ID: 28441080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
